Akèy › Kansè Poumon ki pa ti selil › Georgia › Savannah
Etid klinik pou Kansè Poumon ki pa ti selil nan Savannah, GA
10 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Savannah (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi lwen
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Ap rekriteFaz 3
- Low Country Cancer Care ( Site 0156), Savannah
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Ap rekriteFaz 3
- Lewis Cancer and Research Pavilion ( Site 0063), Savannah
- Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi lwen
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Research Site, Savannah
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Summit Cancer Care PC, Savannah
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi lwen
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
Ap rekriteFaz 3
- Curtis and Elizabeth Anderson Cancer, Savannah
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
- Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi lwen
- The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island · 22 mi lwen
- ak 1 plis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Savannah
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Savannah
- Kansè nan tete11 etid
- Kansè poumon10 etid
- Kansè (tout kalite)6 etid
- Twoub depresif majè6 etid
- Dyabèt Tip 26 etid
- Melanom5 etid
- BPCO5 etid
- Kansè ovè4 etid
- Kansè kolorektal4 etid
- Limfòm Non-Hodgkin3 etid
- Mani3 etid
- Leksemi mieloïd egi3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.